300238SZSE

Guanhao Biotech Co., Ltd.

冠昊生物

300238

Shenzhen Stock Exchange

Follow
48 announcements tracked· Last: April 28, 2026

Key Financials

As of 2026-05-23T00:00:00.000+00:00
Revenue¥93.4M
Net Profit¥10.2M
ROE1.75%
Debt Ratio37.13%
Monetary Funds¥144.2M
Receivables¥61.1M
Total Shares265.2M

Announcements

48 total

Announcement on Appointing a Special Audit Institution for Issuing Stocks to Specific Objects through Simplified Procedures in 2026

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Lifting of Freezing and the Effectiveness of the Pending Freeze on Shares of the Company's Controlling Shareholder's Concerted Actors

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Exemption from Preparing Previous Fund Usage Reports

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Shareholder Dividend Return Plan for the Next Three Years (2026-2028)

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Company's Regulatory Measures or Penalties Taken by Securities Regulatory Authorities and Stock Exchanges in the Last Five Years

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Non-Existence of Financial Assistance or Compensation Provided to Investors Participating in Subscriptions through Direct or Indirect Means by Related Parties for Issuing Stocks to Specific Objects through Simplified Procedures in 2026

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Dilution of Immediate Returns and Measures to Compensate and Commitments from Relevant Parties for Issuing Stocks to Specific Objects through Simplified Procedures in 2026

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Reminder Announcement on the Proposal for Issuing Stocks to Specific Objects through Simplified Procedures in 2026

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Feasibility Analysis Report on the Use of Funds Raised from Issuing Stocks to Specific Objects through Simplified Procedures in 2026

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Analysis Report on the Issuance Plan for Stocks to Specific Objects through Simplified Procedures in 2026

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Proposal for Issuing Stocks to Specific Objects through Simplified Procedures in 2026

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Resolution Announcement of the 19th Meeting of the 6th Board of Directors

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2026 Q1 Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Legal opinion from Beijing Tianyuan Law Firm on the 2025 Annual General Meeting of Guanhao Biotechnology Co., Ltd.

Share PledgeShareholding Change DisclosureCapital Reduction

Announcement of the 2025 Annual General Meeting Resolution

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Notice on the Convening of the 2025 Annual Shareholders' Meeting

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on Re-appointment of the Company's Audit Firm for 2026

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Remuneration Plan for Directors and Senior Management

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Annual Independent Director Performance Report - Deng Chao

Convertible BondsShareholding Change DisclosureCapital Reduction

2025 Annual Independent Director Performance Report - Han Junmei

Convertible BondsShareholding Change DisclosureCapital Reduction

Announcement on Convening the 2025 Annual Performance Online Briefing Session

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Annual Internal Control Audit Report

Share PledgeShareholding Change DisclosureCapital Reduction

2025 Annual Internal Control Evaluation Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Directors' and Senior Management's Remuneration Management System (March 2026)

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Internal Audit System (March 2026)

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Prompt Announcement of 2025 Annual Report Disclosure

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Annual Financial Settlement Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Company's Application for a Comprehensive Bank Credit Line for 2026

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on Undistributed Losses Reaching One-Third of the Total Paid-in Capital

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Company's Provision for Impairment and Write-off of Assets for 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Independent Director Candidate Statement and Commitment

Share Repurchase CompletionConvertible BondsShareholding Change Disclosure

Announcement on the Expiry of Term of Independent Directors and the Election of New Independent Directors and Special Committee Members

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Independent Director Nominee Statement and Commitment

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Estimated Daily Related Party Transactions of the Company for 2026

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Notice of Convening the 2025 Annual General Meeting of Shareholders

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Resolutions Announcement of the Eighteenth Meeting of the Sixth Board of Directors

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Special Explanation on the Company's Proposed Non-Distribution of Profits in 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Non-Recurring Gains and Losses Review Report

Share PledgeShareholding Change DisclosureCapital Reduction

Report of the Board of Directors' Audit Committee on the Assessment of the Accounting Firm's Performance in 2025 and the Fulfillment of Supervision Responsibilities

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Special Audit Report on Non-Operating Fund Occupancy and Other Related Party Fund Transactions in 2025

Share Repurchase CompletionShare PledgeShareholding Change Disclosure

Summary Table of Non-Operating Fund Occupancy and Other Related Party Fund Transactions in 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Board of Directors' Special Opinion on the Independence of Independent Directors

Share Repurchase CompletionConvertible BondsShareholding Change Disclosure

2025 Annual Audit Report

Share PledgeShareholding Change DisclosureCapital Reduction

2025 Annual Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Annual Report Summary

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on Requesting the General Meeting of Shareholders to Authorize the Board of Directors to Handle the Issuance of Shares to Specific Objects through a Simplified Procedure

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on Supplementary Tax Payment

Share Repurchase PlanShareholding Change DisclosureCapital Reduction

Announcement Regarding the Expiration of Independent Directors' Terms

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction